Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity
- PMID: 1782732
Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity
Abstract
In order to assess the immunogenicity of a two-dose regimen of Haemophilus influenzae type b polysaccharide vaccine, the immune response to vaccine given at both 18 and 24 months of age was compared to the response to a single dose at 24 months of age. Following immunization at 24 months of age, the geometric mean antibody concentration of children previously immunized at 18 months (0.53 micrograms/ml) was significantly lower than that of children who received a single dose of vaccine at 24 months (1.03 micrograms/ml; p = 0.03). A four-fold rise in antibody concentration was demonstrated in 31% of children who had received two immunizations and 53% of children immunized for the first time at 24 months of age (p = 0.02). These results suggest that the administration of a dose of plain polysaccharide vaccine at 18 months of age blunted the response to reimmunization at 24 months of age. A subgroup of children who failed to respond to one or two doses of plain polysaccharide vaccine were immunized with polysaccharide-diphtheria toxoid conjugate vaccine. The majority of these children developed a significant rise in antibody concentration in response to conjugate vaccine.
Similar articles
-
Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.Pediatrics. 1990 Mar;85(3):288-93. Pediatrics. 1990. PMID: 2304781 Clinical Trial.
-
Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.Pediatrics. 1990 Apr;85(4 Pt 2):682-9. Pediatrics. 1990. PMID: 2107519 Clinical Trial.
-
IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.Pediatr Res. 1988 Aug;24(2):180-5. doi: 10.1203/00006450-198808000-00008. Pediatr Res. 1988. PMID: 3263612
-
Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.Dev Biol Stand. 1986;65:113-21. Dev Biol Stand. 1986. PMID: 3549393 Review.
-
Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.Pediatrics. 1990 Apr;85(4 Pt 2):698-704. Pediatrics. 1990. PMID: 2107522 Review.